As the company prepared to emerge from stealth mode, timed to JP Morgan’s annual conference, Addition was looking for professional branding, an investor presentation, and a website. The company needed help translating highly technical information about its first-of-its-kind platform to external audiences through a cohesive set of materials.

Working closely with the Addition team, our scientific marketing team dove deep into the technicalities behind their platform, which enabled us to distill it into clear messages and illustrative visuals. We created confidential and non-confidential investor decks, a website that cohesively communicates the message alongside the deck, and supporting materials to help them announce their launch out of stealth.

The result was a successful launch and a $100 million in financing, which led to the expansion of the team, giving them a strong foundation to create durable therapies for chronic and rare diseases.